1st Quarter - Report

CEPI-U.S. for CEPI-U.S.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations House Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023 Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023

Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.

LobbyistCovered position, as disclosed
DANIEL SKALLMAN —

Contacted: Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 1605 (117th), H.R. 2118 (117th), H.R. 4373 (117th), H.R. 4350 (117th)

Budget/Appropriations BUD

Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations House Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023 Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023

Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.

LobbyistCovered position, as disclosed
DANIEL SKALLMAN —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Agency for International Development (USAID); SENATE; White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 4350 (117th), H.R. 2118 (117th), S. 1605 (117th), H.R. 4373 (117th)

Health Issues HCR

Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations S. 2640, Disease X Act, general support for legislation S.3799, PREVENT Pandemics Act, Titles 3,4 and 5, provisions related to vaccine research and development House Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, FY2023 Senate Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, FY2023

Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.

LobbyistCovered position, as disclosed
DANIEL SKALLMAN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; State, Dept of (DOS); U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 2640 (117th), H.R. 2118 (117th), S. 3799 (117th), H.R. 4350 (117th), H.R. 4373 (117th), S. 1605 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.